Cognitive deficits in Rett syndrome: What we know and what we need to know to treat them

Neurobiology of Learning and Memory

Volumn 96, Issue 4, 2011, Pages 637-646

  Berger Sweeney, Joanne ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Cognitive; Cortex; Critical periods; Mental retardation; Rett syndrome

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

AUTISM; BEHAVIOR; BONE DISEASE; BRAIN NERVE CELL; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; NERVE CELL NETWORK; PHENOTYPE; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; RETT SYNDROME; REVIEW; SOCIAL DISABILITY; TRANSCRIPTION REGULATION;

COGNITION DISORDERS; HUMANS; INTELLECTUAL DISABILITY; RETT SYNDROME;

EID: 82355186004     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2011.05.006     Document Type: Review

References (135)

1. Abdala A.P., Dutschmann M., Bissonnette J.M., Paton J.F. Correction of respiratory disorders in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:18208-18213.
2. Abuhatzira L., Makedonski K., Kaufman Y., Razin A., Shemer R. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics 2007, 2:214-222.
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999, 23:185-188.
4. Andrews G., Pine D.S., Hobbs M.J., Anderson T.M., Sunderland M. Neurodevelopmental disorders: Cluster 2 of the proposed meta-structure for DSM-V and ICD-11. Psychological Medicine 2009, 39:2013-2023.
5. Armstrong D., Dunn J.K., Antalffy B., Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. Journal of Neuropathology and Experimental Neurology 1995, 54:195-201.
6. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiology of Disease 2006, 21:217-227.
7. Asthana J.C., Sinha S., Haslam J.S., Kingston H.M. Survey of adolescents with severe intellectual handicap. Archives of Disease in Childhood 1990, 65:1133-1136.
8. Balmer D., Goldstine J., Rao Y.M., LaSalle J.M. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. Journal of Molecular Medicine 2003, 81:61-68.
9. Banerjee P., Schoenfeld B.P., Bell A.J., Choi C.H., Bradley M.P., Hinchey P., et al. Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein. Journal of Neuroscience 2010, 30:6782-6792.
10. Baptista P.M., Mercadante M.T., Macedo E.C., Schwartzman J.S. Cognitive performance in Rett syndrome girls: A pilot study using eyetracking technology. Journal of Intellectual Disability Research 2006, 50:662-666.
11. Bayer S.A., Altman J., Russo R.J., Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 1993, 14:83-144.
12. Becker L.E., Armstrong D.L., Chan F. Dendritic atrophy in children with Down's syndrome. Annals of Neurology 1986, 20:520-526.
13. Belichenko P.V., Oldfors A., Hagberg B., Dahlstrom A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. NeuroReport 1994, 5:1509-1513.
14. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., et al. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: Evidence for disruption of neuronal networks. Journal of Comparative Neurology 2009, 514:240-258.
15. Berger-Sweeney J., Hohmann C.F. Behavioral consequences of abnormal cortical development: Insights into developmental disabilities. Behavioural Brain Research 1997, 86:121-142.
16. Bienvenu T., Chelly J. Molecular genetics of Rett syndrome: When DNA methylation goes unrecognized. Nature Reviews Genetics 2006, 7:415-426.
17. Borello U., Pierani A. Patterning the cerebral cortex: Traveling with morphogens. Current Opinion in Genetics and Development 2010, 20:408-415.
18. Cass H., Reilly S., Owen L., Wisbeach A., Weekes L., Slonims V., et al. Findings from a multidisciplinary clinical case series of females with Rett syndrome. Developmental Medicine and Child Neurology 2003, 45:325-337.
19. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
20. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: From clinic to neurobiology. Neuron 2007, 56:422-437.
21. Chang Q., Khare G., Dani V., Nelson S., Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49:341-348.
22. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
23. Chao H.T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65.
24. Chapleau C.A., Larimore J.L., Theibert A., Pozzo-Miller L. Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: Fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. Journal of Neurodevelopmental Disorders 2009, 1:185-196.
25. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genetics 2001, 27:327-331.
26. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302:885-889.
27. Cobb S., Guy J., Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochemical Society Transactions 2010, 38:498-506.
28. Cohen D.R., Matarazzo V., Palmer A.M., Tu Y., Jeon O.H., Pevsner J., et al. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Molecular and Cellular Neurosciences 2003, 22:417-429.
29. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Human Molecular Genetics 2004, 13:2679-2689.
30. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12560-12565.
31. Dani V.S., Nelson S.B. Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. Journal of Neuroscience 2009, 29:11263-11270.
32. de Villers-Sidani E., Simpson K.L., Lu Y.F., Lin R.C., Merzenich M.M. Manipulating critical period closure across different sectors of the primary auditory cortex. Nature Neuroscience 2008, 11:957-965.
33. del Gaudio D., Fang P., Scaglia F., Ward P.A., Craigen W.J., Glaze D.G., et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genetics in Medicine 2006, 8:784-792.
34. Demeter K. Assessing the developmental level in Rett syndrome: An alternative approach?. European Child and Adolescent Psychiatry 2000, 9:227-233.
35. Desai N.S., Cudmore R.H., Nelson S.B., Turrigiano G.G. Critical periods for experience-dependent synaptic scaling in visual cortex. Nature Neuroscience 2002, 5:783-789.
36. Dierssen M., Ramakers G.J. Dendritic pathology in mental retardation: From molecular genetics to neurobiology. Genes, Brain and Behavior 2006, 5(Suppl. 2):48-60.
37. Dolen G., Carpenter R.L., Ocain T.D., Bear M.F. Mechanism-based approaches to treating fragile X. Pharmacology and Therapeutics 2010, 127:78-93.
38. Edgin J.O., Pennington B.F., Mervis C.B. Neuropsychological components of intellectual disability: The contributions of immediate, working, and associative memory. Journal of Intellectual Disability Research 2010, 54:406-417.
39. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., et al. Reversal of learning deficits in a Tsc2± mouse model of tuberous sclerosis. Nature Medicine 2008, 14:843-848.
40. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
41. Einspieler C., Kerr A.M., Prechtl H.F. Is the early development of girls with Rett disorder really normal?. Pediatric Research 2005, 57:696-700.
42. Fagiolini M., Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 2000, 404:183-186.
43. Fontanesi J., Haas R.H. Cognitive profile of Rett syndrome. Journal of Child Neurology 1988, 3(Suppl.):S20-S24.
44. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. Journal of Neuropathology and Experimental Neurology 2005, 64:537-544.
45. Gambino F., Khelfaoui M., Poulain B., Bienvenu T., Chelly J., Humeau Y. Synaptic maturation at cortical projections to the lateral amygdala in a mouse model of Rett syndrome. PLoS ONE 2010, 5:e11399.
46. Garber N., Veydt N. Rett syndrome: A longitudinal developmental case report. Journal of Communication Disorders 1990, 23:61-75.
47. Gatto C.L., Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Frontiers in Synaptic Neuroscience 2010, 2:4.
48. Gemelli T., Berton O., Nelson E.D., Perrotti L.I., Jaenisch R., Monteggia L.M. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biological Psychiatry 2005.
49. Gibson J.H., Slobedman B., NH K., Williamson S.L., Minchenko D., El-Osta A., et al. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neuroscience 2010, 11:53.
50. Glaze D.G. Neurophysiology of Rett syndrome. Journal of Child Neurology 2005, 20:740-746.
51. Gonzales M.L., LaSalle J.M. The role of MeCP2 in brain development and neurodevelopmental disorders. Current Psychiatry Reports 2010, 12:127-134.
52. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
53. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics 2001, 27:322-326.
54. Hagberg B., Aicardi J., Dias K., Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Annals of Neurology 1983, 14:471-479.
55. Hagberg H., Peebles D., Mallard C. Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Mental Retardation and Developmental Disabilities Research Reviews 2002, 8:30-38.
56. Hagberg B., Witt-Engerstrom I. Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence. American Journal of Medical Genetics. Supplement 1986, 1:47-59.
57. Hamberger A., Gillberg C., Palm A., Hagberg B. Elevated CSF glutamate in Rett syndrome. Neuropediatrics 1992, 23:212-213.
58. Hashimoto R., Backer K.C., Tassone F., Hagerman R.J., Rivera S.M. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Journal of Psychiatric Research 2011, 45:36-43.
59. Hensch T.K. Critical period plasticity in local cortical circuits. Nature Reviews Neuroscience 2005, 6:877-888.
60. Hensch T.K., Fagiolini M., Mataga N., Stryker M.P., Baekkeskov S., Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998, 282:1504-1508.
61. Holtmaat A.J., Trachtenberg J.T., Wilbrecht L., Shepherd G.M., Zhang X., Knott G.W., et al. Transient and persistent dendritic spines in the neocortex in vivo. Neuron 2005, 45:279-291.
62. Hubel D.H., Wiesel T.N. Stereoscopic vision in macaque monkey. Cells sensitive to binocular depth in area 18 of the macaque monkey cortex. Nature 1970, 225:41-42.
63. Iwai Y., Fagiolini M., Obata K., Hensch T.K. Rapid critical period induction by tonic inhibition in visual cortex. Journal of Neuroscience 2003, 23:6695-6702.
64. Jentarra G.M., Olfers S.L., Rice S.G., Srivastava N., Homanics G.E., Blue M., et al. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neuroscience 2010, 11:19.
65. Johnston M.V., Alemi L., Harum K.H. Learning, memory, and transcription factors. Pediatric Research 2003, 53:369-374.
66. Johnston M.V., Jeon O.H., Pevsner J., Blue M.E., Naidu S. Neurobiology of Rett syndrome: A genetic disorder of synapse development. Brain and Development 2001, 23(Suppl. 1):S206-S213.
67. Johnston M.V., Mullaney B., Blue M.E. Neurobiology of Rett syndrome. Journal of Child Neurology 2003, 18:688-692.
68. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends in Neurosciences 2010, 33:121-129.
69. Kaufmann W.E., MacDonald S.M., Altamura C.R. Dendritic cytoskeletal protein expression in mental retardation: An immunohistochemical study of the neocortex in Rett syndrome. Cerebral Cortex 2000, 10:992-1004.
70. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cerebral Cortex 2000, 10:981-991.
71. Kaufmann W.E., Taylor C.V., Hohmann C.F., Sanwal I.B., Naidu S. Abnormalities in neuronal maturation in Rett syndrome neocortex: Preliminary molecular correlates. European Child and Adolescent Psychiatry 1997, 6(Suppl. 1):75-77.
72. Kishi N., Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Molecular and Cellular Neurosciences 2004, 27:306-321.
73. Kishi N., Macklis J.D. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Experimental Neurology 2010, 222:51-58.
74. Kogan C.S., Cornish K.M. Mapping self-reports of working memory deficits to executive dysfunction in Fragile X Mental Retardation 1 (FMR1) gene premutation carriers asymptomatic for FXTAS. Brain and Cognition 2010, 73:236-243.
75. Kondo M., Gray L.J., Pelka G.J., Christodoulou J., Tam P.P., Hannan A.J. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome -Mecp2 gene dosage effects and BDNF expression. European Journal of Neuroscience 2008.
76. Lappalainen R., Riikonen R.S. High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatric Neurology 1996, 15:213-216.
77. Lasalle J.M., Yasui D.H. Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics 2009, 1:119-130.
78. Lawson-Yuen A., Liu D., Han L., Jiang Z.I., Tsai G.E., Basu A.C., et al. Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Research 2007, 1180:1-6.
79. Lenneberg E.H. On explaining language. Science 1969, 164:635-643.
80. Lonetti G., Angelucci A., Morando L., Boggio E.M., Giustetto M., Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biological Psychiatry 2010, 67:657-665.
81. Lott I.T., Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. The Lancet Neurology 2010, 9:623-633.
82. Lubin F.D., Gupta S., Parrish R.R., Grissom N.M., Davis R.L. Epigenetic mechanisms: Critical contributors to long-term memory formation. Neuroscientist 2011.
83. Lujan R., Shigemoto R., Lopez-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005, 130:567-580.
84. Lush M.E., Ma L., Parada L.F. TrkB signaling regulates the developmental maturation of the somatosensory cortex. International Journal of Developmental Neuroscience 2005, 23:523-536.
85. Maezawa I., Jin L.W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. Journal of Neuroscience 2010, 30:5346-5356.
86. Mantis J.G., Fritz C.L., Marsh J., Heinrichs S.C., Seyfried T.N. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets. Epilepsy & Behavior 2009, 15:133-141.
87. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
88. Matijevic T., Knezevic J., Slavica M., Pavelic J. Rett syndrome: From the gene to the disease. European Neurology 2009, 61:3-10.
89. McBride S.M., Choi C.H., Wang Y., Liebelt D., Braunstein E., Ferreiro D., et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 2005, 45:753-764.
90. Minichiello L. TrkB signalling pathways in LTP and learning. Nature Reviews Neuroscience 2009, 10:850-860.
91. Mitsuhashi T., Yonemoto J., Sone H., Kosuge Y., Kosaki K., Takahashi T. In utero exposure to dioxin causes neocortical dysgenesis through the actions of p27Kip1. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:16331-16335.
92. Molnar, Z., Hoerder-Suabedissen, A., Wang, W. Z., DeProto, J., Davies, K., Lee, S., et al. (2007). Genes involved in the formation of the earliest cortical circuits. In Novartis found symposium (vol. 288, pp. 212-224). Discussion 224-219, 276-281.
93. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Teague R., Antalffy B., et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. Journal of Neuroscience 2006, 26:319-327.
94. Mullaney B.C., Johnston M.V., Blue M.E. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 2004, 123:939-949.
95. Nag N., Berger-Sweeney J.E. Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome. Neurobiology of Disease 2007, 26:473-480.
96. Nag N., Mellott T.J., Berger-Sweeney J.E. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome. Brain Research 2008, 1237:101-109.
97. Nag N., Moriuchi J.M., Peitzman C.G., Ward B.C., Kolodny N.H., Berger-Sweeney J.E. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice. Behavioural Brain Research 2009, 196:44-48.
98. Naidu S. Rett syndrome: Natural history and underlying disease mechanisms. European Child and Adolescent Psychiatry 1997, 6(Suppl. 1):14-17.
99. Naidu S., Kaufmann W.E., Abrams M.T., Pearlson G.D., Lanham D.C., Fredericksen K.A., et al. Neuroimaging studies in Rett syndrome. Brain and Development 2001, 23(Suppl. 1):S62-S71.
100. Nelson E.D., Kavalali E.T., Monteggia L.M. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Current Biology 2006, 16:710-716.
101. Nissenkorn A., Gak E., Vecsler M., Reznik H., Menascu S., Ben Zeev B. Epilepsy in Rett syndrome - The experience of a National Rett Center. Epilepsia 2010, 51:1252-1258.
102. Ogier M., Wang H., Hong E., Wang Q., Greenberg M.E., Katz D.M. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. Journal of Neuroscience 2007, 27:10912-10917.
103. Pelka G.J., Watson C.M., Radziewic T., Hayward M., Lahooti H., Christodoulou J., et al. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898.
104. Picker J.D., Yang R., Ricceri L., Berger-Sweeney J. An altered neonatal behavioral phenotype in Mecp2 mutant mice. NeuroReport 2006, 17:541-544.
105. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
106. Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M., Schaaf C.P., et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Annals of Neurology 2009, 66:771-782.
107. Ricceri L., De Filippis B., Laviola G. Mouse models of Rett syndrome: From behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behavioural Pharmacology 2008, 19:501-517.
108. Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome. Journal of Child Neurology 2003, 18:693-697.
109. Roux J.C., Dura E., Moncla A., Mancini J., Villard L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. European Journal of Neuroscience 2007, 25:1915-1922.
110. Rubenstein J.L. Research review: Development of the cerebral cortex: Implications for neurodevelopmental disorders. Journal of Child Psychology and Psychiatry 2010.
111. Santos M., Summavielle T., Teixeira-Castro A., Silva-Fernandes A., Duarte-Silva S., Marques F., et al. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 2010, 170:453-467.
112. Schaevitz L.R., Moriuchi J.M., Nag N., Mellot T.J., Berger-Sweeney J. Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiology & Behavior 2010, 100:255-263.
113. Shahbazian M.D., Antalffy B., Armstrong D.L., Zoghbi H.Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Human Molecular Genetics 2002, 11:115-124.
114. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
115. Silva A.J., Ehninger D. Adult reversal of cognitive phenotypes in neurodevelopmental disorders. Journal of Neurodevelopmental Disorders 2009, 1:150-157.
116. Stauder J.E., Smeets E.E., van Mil S.G., Curfs L.G. The development of visual- and auditory processing in Rett syndrome: An ERP study. Brain and Development 2006, 28:487-494.
117. Stearns N.A., Schaevitz L.R., Bowling H., Nag N., Berger U.V., Berger-Sweeney J. Behavioral and anatomical abnormalities in Mecp2 mutant mice. A model for Rett syndrome. Neuroscience 2007, 146:907-921.
118. Takashima S., Becker L.E., Armstrong D.L., Chan F. Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study. Brain Research 1981, 225:1-21.
119. Taneja P., Ogier M., Brooks-Harris G., Schmid D.A., Katz D.M., Nelson S.B. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. Journal of Neuroscience 2009, 29:12187-12195.
120. Tolwani R.J., Buckmaster P.S., Varma S., Cosgaya J.M., Wu Y., Suri C., et al. BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 2002, 114:795-805.
121. Trachtenberg J.T., Chen B.E., Knott G.W., Feng G., Sanes J.R., Welker E., et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002, 420:788-794.
122. Trauner D.A., Haas R.H. Electroencephalographic abnormalities in Rett syndrome. Pediatric Neurology 1987, 3:331-334.
123. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2029-2034.
124. Van Esch H., Bauters M., Ignatius J., Jansen M., Raynaud M., Hollanders K., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. American Journal of Human Genetics 2005, 77:442-453.
125. Velloso Rde L., de Araujo C.A., Schwartzman J.S. Concepts of color, shape, size and position in ten children with Rett syndrome. Arquivos de Neuro-Psiquiatria 2009, 67:50-54.
126. Viola A., Saywell V., Villard L., Cozzone P.J., Lutz N.W. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS ONE 2007, 2:e157.
127. Ward B.C., Kolodny N.H., Nag N., Berger-Sweeney J.E. Neurochemical changes in a mouse model of Rett syndrome: Changes over time and in response to perinatal choline nutritional supplementation. Journal of Neurochemistry 2009, 108:361-371.
128. Weeber E.J., Levenson J.M., Sweatt J.D. Molecular genetics of human cognition. Molecular Interventions 2002, 2:376-391, 339.
129. Wenk G.L., Hauss-Wegrzyniak B. Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics 1999, 30:125-129.
130. Wetmore D.Z., Garner C.C. Emerging pharmacotherapies for neurodevelopmental disorders. Journal of Developmental and Behavioral Pediatrics 2010, 31:564-581.
131. Woodyatt G.C., Ozanne A.E. A longitudinal study of cognitive skills and communication behaviours in children with Rett syndrome. Journal of Intellectual Disability Research 1993, 37(Pt 4):419-435.
132. Zanella S., Mebarek S., Lajard A.M., Picard N., Dutschmann M., Hilaire G. Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respiratory Physiology & Neurobiology 2008, 160:116-121.
133. Zhang L., He J., Jugloff D.G., Eubanks J.H. The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 2008, 18:294-309.
134. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L., et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52:255-269.
135. Zoghbi H.Y., Percy A.K., Glaze D.G., Butler I.J., Riccardi V.M. Reduction of biogenic amine levels in the Rett syndrome. New England Journal of Medicine 1985, 313:921-924.